Clinical Trial Update: BVAIT: B-Vitamin Atherosclerosis Intervention Trial [Phase 2, Phase 3]

View source ↗

Summary

The BVAIT trial evaluated B-vitamin therapy for atherosclerosis in Phase 2 and Phase 3, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• B-Vitamins (folic acid, vitamin B6, and vitamin B12) combination (B vitamins – folic acid, pyridoxine, and cobalamin)

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Atherosclerosis | Phase 2, Phase 3 | Status: COMPLETED